UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

PloS one, 2019-01, Vol.14 (1), p.e0210415-e0210415

2019

Volltextzugriff (PDF)

The prevention of contrast-induced nephropathy

The Annals of pharmacotherapy, 2014-10, Vol.48 (10), p.1332

2014

Volltextzugriff (PDF)

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Cancer epidemiology, biomarkers & prevention, 2021-06, Vol.30 (6), p.1106-1113

2021

Volltextzugriff (PDF)

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Supportive care in cancer, 2022-02, Vol.30 (2), p.1365-1375

2022

Volltextzugriff (PDF)

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Oncotarget, 2022-12, Vol.13 (1), p.1306-1306

2022

Volltextzugriff (PDF)

Impact of a genetic counseling requirement prior to genetic testing

BMC health services research, 2018-03, Vol.18 (1), p.165-165, Article 165

2018

Volltextzugriff (PDF)

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Oncotarget, 2022-01, Vol.13 (1), p.257-270

2022

Volltextzugriff (PDF)

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

Journal of gastrointestinal oncology, 2017-06, Vol.8 (3), p.387-404

2017

Volltextzugriff (PDF)

Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study

Future oncology (London, England), 2023-01, Vol.19 (2), p.173-188

2023

Volltextzugriff (PDF)

Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Supportive care in cancer, 2022-02, Vol.30 (2), p.1377-1378

2022

Volltextzugriff (PDF)

Hepatitis C therapy: Looking toward interferon-sparing regimens

Journal of the American Pharmacists Association, 2015-03, Vol.55 (2), p.e72-e86

2015

Volltextzugriff (PDF)

A Retrospective Analysis of Dexmedetomidine Use for Alcohol Withdrawal Syndrome in Critical Care Patients

Chest, 2014-10, Vol.146 (4), p.225A-225A

2014

Volltextzugriff (PDF)

Ceritinib: A primer for pharmacists

Journal of Oncology Pharmacy Practice, 2017-12, Vol.23 (8), p.602-614

2017

Volltextzugriff (PDF)

Evaluation of the relevance and access of EHR-based variables to support personalized medicine in breast cancer

Cogent medicine, 2016-12, Vol.3 (1), p.1234661

2016

Volltextzugriff (PDF)

Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials

Journal of managed care & specialty pharmacy, 2021-10, Vol.27 (10), p.1367

2021

Volltextzugriff (PDF)

Challenges and opportunities of alternative payment models for physicians/quality officers in community/academic oncology practice sites via a national prospective survey

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.46-46

2021

Volltextzugriff (PDF)

Treatments and outcomes for patients with myelodysplastic syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) scores at the Huntsman Cancer Institute (HCI)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19034-e19034

2021

Volltextzugriff (PDF)

Treatments and Outcomes for Patients at Academic Cancer Centers with Myelodysplastic Syndrome (MDS) By Revised International Prognostic Scoring System (IPSS-R) Scores

Blood, 2022-11, Vol.140 (Supplement 1), p.5291-5292

2022

Volltextzugriff (PDF)

Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts

Journal of clinical oncology, 2017-03, Vol.35 (8_suppl), p.66-66

2017

Volltextzugriff (PDF)

Cost-effectiveness of genotype-guided aspirin use for colorectal cancer prevention

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18318-e18318

2017

Volltextzugriff (PDF)

Smaller frontal lobe white matter volumes in depressed adolescents

Biological psychiatry (1969), 2002-09, Vol.52 (5), p.413-417

2002

Volltextzugriff (PDF)

Poster: MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S229-S229

2021

Volltextzugriff (PDF)

MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S349-S349

2021

Volltextzugriff (PDF)

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Blood, 2018-11, Vol.132 (Supplement 1), p.4745-4745

2018

Volltextzugriff (PDF)

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Blood, 2018-11, Vol.132 (Supplement 1), p.5857-5857

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(19)
Life Sciences & Biomedicine
(17)
Oncology
(10)
Female
(6)
Life Sciences
(6)
Adult
(5)
Chemistry
(5)
Child
(5)
Male
(5)
Materials Science
(5)
Technology
(5)
Carbon
(4)
Humanities And Social Sciences
(4)
Materials Science, Multidisciplinary
(4)
Medicine
(4)
Middle Aged
(4)
Mutation
(4)
Pharmacology & Pharmacy
(4)
Physical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

The prevention of contrast-induced nephropathy

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Impact of a genetic counseling requirement prior to genetic testing

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study

Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Hepatitis C therapy: Looking toward interferon-sparing regimens

A Retrospective Analysis of Dexmedetomidine Use for Alcohol Withdrawal Syndrome in Critical Care Patients

Ceritinib: A primer for pharmacists

Evaluation of the relevance and access of EHR-based variables to support personalized medicine in breast cancer

Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials

Challenges and opportunities of alternative payment models for physicians/quality officers in community/academic oncology practice sites via a national prospective survey

Treatments and outcomes for patients with myelodysplastic syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) scores at the Huntsman Cancer Institute (HCI)

Treatments and Outcomes for Patients at Academic Cancer Centers with Myelodysplastic Syndrome (MDS) By Revised International Prognostic Scoring System (IPSS-R) Scores

Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts

Cost-effectiveness of genotype-guided aspirin use for colorectal cancer prevention

Smaller frontal lobe white matter volumes in depressed adolescents

Poster: MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

MDS-370: Treatments and Outcomes for Patients with Myelodysplastic Syndromes (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Suchergebnisse filtern